Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

breast cancer resistance protein

(brest KAN-ser reh-ZIH-stunts PROH-teen)
A protein that is involved in making cancer cells resistant (unable to respond) to anticancer drugs. Normally, breast cancer resistance protein works with other proteins to help move many different substances, including drugs and other chemicals, in and out of cells. It is found in stem cells and in normal tissues, including the intestine, liver, brain, and placenta. However, it may also be found in higher than normal amounts in some cancer cells, which can cause them to be unable to respond to certain anticancer drugs. Drugs that block breast cancer resistance protein are being studied in the treatment of some types of cancer. Breast cancer resistance protein was first identified in breast cancer cells. Also called BCRP.
Search NCI's Dictionary of Cancer Terms